Orchard Therapeutics Balance Sheet

Financials in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2016 - 2020
Cash & Equivalents	499.2	701.75	430.4	663.67	300.4	350.3	Upgrade
Trading Asset Securities	-	786.04	1,352	228.41	-	-	Upgrade
Cash & Short-Term Investments	658.57	1,488	1,783	892.08	300.4	350.3	Upgrade
Cash Growth	-74.48%	-16.54%	99.83%	196.97%	-14.24%	21.94%	Upgrade
Accounts Receivable	2,420	2,205	2,246	1,547	452.8	510.35	Upgrade
Other Receivables	842.4	721.97	803.72	539.4	462.15	355.53	Upgrade
Receivables	3,518	2,945	3,065	2,143	962.35	870.72	Upgrade
Inventory	1,807	1,537	1,689	1,569	1,153	594.97	Upgrade
Prepaid Expenses	-	23.06	29.74	23.43	16.68	14.64	Upgrade
Other Current Assets	55.87	280.89	101.2	5.25	5.56	21.57	Upgrade
Total Current Assets	6,039	6,274	6,667	4,632	2,438	1,852	Upgrade
Property, Plant & Equipment	5,959	5,607	3,248	3,140	1,811	1,664	Upgrade
Other Intangible Assets	-	2.46	2.74	3.04	-	-	Upgrade
Other Long-Term Assets	29.78	29.78	44.27	35.32	29.35	16.88	Upgrade
Total Assets	12,054	11,935	9,982	7,830	4,297	3,550	Upgrade
Accounts Payable	2,109	1,983	1,843	1,190	722.73	609.99	Upgrade
Accrued Expenses	0.63	262.44	327.8	236.86	81.07	39.54	Upgrade
Short-Term Debt	590	250	-	791.01	-	-	Upgrade
Current Portion of Long-Term Debt	4.11	4.11	1.14	0.85	-	-	Upgrade
Current Portion of Leases	3.06	2.16	-	-	-	-	Upgrade
Current Unearned Revenue	-	65	46.27	25.87	40.7	22.53	Upgrade
Other Current Liabilities	3.96	32.74	18.18	7.91	0.01	0.01	Upgrade
Total Current Liabilities	2,710	2,600	2,236	2,252	844.51	672.07	Upgrade
Long-Term Debt	29.42	32.51	9.11	10.25	-	-	Upgrade
Long-Term Leases	3.79	4.04	-	-	-	-	Upgrade
Long-Term Deferred Tax Liabilities	238.68	368.28	-	-	-	-	Upgrade
Total Liabilities	3,179	3,195	2,421	2,439	1,019	835.45	Upgrade
Common Stock	170	170	170	170	170	170	Upgrade
Additional Paid-In Capital	63	63	63	63	63	63	Upgrade
Retained Earnings	5,846	5,627	5,193	2,968	1,866	1,254	Upgrade
Comprehensive Income & Other	2,796	2,880	2,135	2,190	1,179	1,227	Upgrade
Shareholders' Equity	8,875	8,740	7,561	5,391	3,278	2,714	Upgrade
Total Liabilities & Equity	12,054	11,935	9,982	7,830	4,297	3,550	Upgrade
Total Debt	630.38	292.82	10.25	802.11	-	-	Upgrade
Net Cash (Debt)	28.18	1,195	1,772	89.97	300.4	350.3	Upgrade
Net Cash Growth	-98.89%	-32.58%	1869.94%	-70.05%	-14.24%	21.94%	Upgrade
Net Cash Per Share	1.79	70.29	104.26	5.29	17.67	20.61	Upgrade
Filing Date Shares Outstanding	17	17	17	17	17	17	Upgrade
Total Common Shares Outstanding	17	17	17	17	17	17	Upgrade
Working Capital	3,329	3,674	4,431	2,380	1,593	1,180	Upgrade
Book Value Per Share	522.05	514.10	444.75	317.12	192.81	159.66	Upgrade
Tangible Book Value	8,875	8,737	7,558	5,388	3,278	2,714	Upgrade
Tangible Book Value Per Share	522.05	513.96	444.59	316.95	192.81	159.66	Upgrade
Land	-	-	1,709	1,709	-	796.9	Upgrade
Buildings	-	-	748.27	678.96	-	565.11	Upgrade
Machinery	-	-	1,268	1,001	-	648.94	Upgrade
Construction In Progress	-	-	145.08	247.88	-	6.25	Upgrade

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.